Agenda
09:00 a.m. | Registration |
09:20 a.m. | Opening Ken Ooi GM Miltenyi Biotec APAC |
09:30 a.m. | The outlook of cell therapy in China Prof. Weidong Han Dept. of Molecular & Immunological, Chinese PLA General Hospital |
10:15 a.m. | Clinical applications of CAR-T cell therapies for refractory/relapsed B-cell acute lymphoblastic leukemia and lymphoma Shuangyou Liu, MD Dept. of Hematology, Beijing Boren Hospital |
11:00 a.m. | Coffee break |
11:30 a.m. | Next generation of therapeutic antibody discovery platform Louis Liu, MD Harbour BioMed Shanghai Co., Ltd. |
12:00 p.m. | The innovative design strategy of CAR-T cells and its treatment on solid tumors Dr. Xiaowen He Shanghai Origincell Biological Cryo Equipment Co., Ltd |
12:30 p.m. | Lunch and networking |
01:15 p.m. | Tour of Origincell & ATLATL activity |
02:00 p.m. | Revealing the heterogeneity and characteristics of ILC subsets on intestinal cancer using single cell RNAseq Prof. Bing Su Shanghai Institute of Immunology |
02:45 p.m. | Towards precise human genome editing for improvement of T cell immunotherapy Prof. XingXu Huang School of Life Science and Technology, ShanghaiTech University |
03:15 p.m. | Immunometabolism in cancer Dr. Duojiao Wu Zhongshan Hospital, Fudan University |
03:45 p.m. | The opportunity and challenge of chemotherapy in the era of tumor immunotherapy Dr. Ming Huang Shanghai Institute of Materia Medica, Chinese Academy of Science |
04:15 p.m. | Introduction of Biologics Innovation Group (BiG) Mrs. Ying Yang LBD Life science/ LAB Direct |
04:30 p.m. | Cocktail networking/ Tour of MITC |
Seems like you are coming from USA!
Do you want to visit our website in your country?